{{Rsnum
|rsid=225190
|Gene=MYO1D
|Chromosome=17
|position=32550640
|Orientation=minus
|GMAF=0.3269
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MYO1D
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 39.8 | 46.0 | 14.2
| HCB | 50.7 | 44.1 | 5.1
| JPT | 41.6 | 43.4 | 15.0
| YRI | 67.3 | 30.6 | 2.0
| ASW | 61.4 | 38.6 | 0.0
| CHB | 50.7 | 44.1 | 5.1
| CHD | 42.1 | 45.8 | 12.1
| GIH | 49.5 | 40.6 | 9.9
| LWK | 80.0 | 18.2 | 1.8
| MEX | 34.5 | 48.3 | 17.2
| MKK | 73.1 | 25.0 | 1.9
| TSI | 41.2 | 44.1 | 14.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20686608
|Trait=None
|Title=Genome-wide association study of pancreatic cancer in Japanese population
|RiskAllele=G
|Pval=0.000006
|OR=1.26
|ORtxt=[1.14-1.39]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}